Effects of aprotinin on activated coagulation time in the patients during cardiopulmonary bypass
Xu, L.; He, Z.; Shen, J.
Hunan Yi Ke da Xue Xue Bao 23(2): 215-216
1998
ISSN/ISBN: 1000-5625 PMID: 10681854 Document Number: 492645
Document emailed within 1 workday
Related Documents
Shikano, K.; Shinpo, H.; Nasu, M.; Morimoto, T.; Suzuki, T.; Yada, I.; Kusagawa, M. 1981: Heparin management by activated coagulation time during cardiopulmonary bypass Kyobu Geka. Japanese Journal of Thoracic Surgery 34(12): 934-937Faulí, A.; Gomar, C.; Campistol, J.M.; Alvarez, L.; Manig, A.M.; Matute, P. 2005: Kidney-specific proteins in patients receiving aprotinin at high- and low-dose regimens during coronary artery bypass graft with cardiopulmonary bypass European Journal of Anaesthesiology 22(9): 666-671
Lu, H.; Du Buit, C.; Soria, J.; Touchot, B.; Chollet, B.; Commin, P.L.; Conseiller, C.; Echter, E.; Soria, C. 1994: Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy Thrombosis and Haemostasis 72(3): 438-443
Akl, B.F.; Vargas, G.M.; Neal, J.; Robillard, J.; Kelly, P. 1980: Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass Journal of Thoracic and Cardiovascular Surgery 79(1): 97-102
Levy, J.H.; Salmenpera, M.T. 1991: Increased anticoagulation during cardiopulmonary bypass by aprotinin Journal of Thoracic and Cardiovascular Surgery 102(5): 802
Ray, M.J.; Marsh, N.A. 1997: Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin Thrombosis and Haemostasis 78(3): 1021-1026
Santamaría, A.; Mateo, J.; Oliver, A.; Litvan, H.; Murillo, J.; Souto, J.C.; Fontcuberta, J. 2000: The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss Haematologica 85(12): 1277-1284
Bidstrup, B.P.; Royston, D.; Sapsford, R.N.; Taylor, K.M. 1989: Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol) Journal of Thoracic and Cardiovascular Surgery 97(3): 364-372
Sakamoto, T.; Asou, T.; Takeda, Y.; Date, K.; Nanaumi, M.; Nagafuchi, H.; Koga, N.; Ohmiya, A.; Chiba, S. 2006: Coagulation and fibrinolysis system in pediatric cardiopulmonary bypass Kyobu Geka. Japanese Journal of Thoracic Surgery 59(13): 1163-1170
Barbe, D.; Bauduer, F.; Tanguy, A. 1991: Prothrombin time, activated partial thromboplastin time, plasma fibrinogen determination. Comparison of two automated coagulation systems: Koagulab 40-A and ACL-100 Annales de Biologie Clinique 49(10): 507-513
Kang, Y.; De Wolf, A.M.; Aggarwal, S.; Campbell, E.; Martin, L.K. 1991: In vitro study of the effects of aprotinin on coagulation during orthotopic liver transplantation Transplantation Proceedings 23(3): 1934-1935
Umlas, J.; Sakhuja, R. 1975: The effect on blood coagulation of the exclusive use of transfusions of frozen red cells during and after cardiopulmonary bypass Journal of Thoracic and Cardiovascular Surgery 70(3): 519-523
Watanabe, A.; Sumita, S.; Ichimiya, T.; Namiki, A. 1994: Effects of ulinastatin on extravascular lung water volume in patients undergoing cardiopulmonary bypass Masui. Japanese Journal of Anesthesiology 43(1): 78-88
Walpoth, B.H.; Eggensperger, N.; Hauser, S.P.; Neidhart, P.; Kurt, G.; Spaeth, P.J.; Althaus, U. 1999: Effects of unprocessed and processed cardiopulmonary bypass blood retransfused into patients after cardiac surgery International Journal of Artificial Organs 22(4): 210-216
Mishima, A.; Takeuti, Y.; Usami, S.; Kotani, H.; Suzuki, Y.; Yura, J. 1990: Effects of ulinastatin on plasma polymorphonuclear leukocyte elastase activity and respiratory function in patients undergoing cardiopulmonary bypass Nihon Kyobu Geka Gakkai 38(4): 607-612
Schiffer, S.P.; Gillett, C.S.; Ringler, D.H. 1984: Activated coagulation time for rhesus monkeys (Macaca mulatta) Laboratory Animal Science 34(2): 191-193
Gotou, K.; Kimura, F.; Kimura, N.; Hashimoto, Y.; Wakayama, S. 1997: The anesthetic management of patients in chronic renal failure for coronary artery bypass surgery without cardiopulmonary bypass Masui. Japanese Journal of Anesthesiology 46(12): 1609-1614
Go, R.; Mori, K.; Abe, T.; Kohyama, A.; Kataoka, Y.; Bandoh, M. 1997: Coronary artery bypass grafting on the beating heart in patients with severe cardiac dysfunction; on the necessity of cardiopulmonary bypass Masui. Japanese Journal of Anesthesiology 46(9): 1209-1214
Daudt, C.A.; Pereira, S.N.; Moraes, L.B.; Costa, P.S.; Deboni, L.M.; Figueiredo, M.S. 1989: Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation Arquivos Brasileiros de Cardiologia 52(3): 137-139
Wang, A.; McCartney, S.L.; Williams, J.B.; Ganapathi, A.; Glower, D.D.; Nicoara, A.; Gaca, J.G. 2017: Use of Adjuncts Reduces Cardiopulmonary Bypass time During Minimally Invasive Aortic Valve Replacement Journal of Heart Valve Disease 26(2): 155-160